(Q37652620)

English

p53 alteration independently predicts poor outcomes in patients with endometrial cancer: a clinicopathologic study of 131 cases and literature review

scientific article published on 14 December 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 August 2017

p53 alteration independently predicts poor outcomes in patients with endometrial cancer: a clinicopathologic study of 131 cases and literature review (English)

1 reference

Europe PubMed Central

21 August 2017

literature review

1 reference

based on heuristic

inferred from title

endometrial cancer

1 reference

based on heuristic

inferred from title

author name string

Eun-Ju Lee

1

1 reference

Europe PubMed Central

21 August 2017

Tae-Joong Kim

2

1 reference

Europe PubMed Central

21 August 2017

Dae Shick Kim

3

1 reference

Europe PubMed Central

21 August 2017

Chel Hun Choi

4

1 reference

Europe PubMed Central

21 August 2017

Jeong-Won Lee

5

1 reference

Europe PubMed Central

21 August 2017

Je-Ho Lee

6

1 reference

Europe PubMed Central

21 August 2017

Duk-Soo Bae

7

1 reference

Europe PubMed Central

21 August 2017

Byoung-Gie Kim

8

1 reference

Europe PubMed Central

21 August 2017

language of work or name

0 references

publication date

14 December 2009

1 reference

Europe PubMed Central

21 August 2017

Gynecologic Oncology

1 reference

Europe PubMed Central

21 August 2017

116

1 reference

Europe PubMed Central

21 August 2017

3

1 reference

Europe PubMed Central

21 August 2017

533-538

1 reference

Europe PubMed Central

21 August 2017

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.018

7 January 2021

Prospective Multicenter Validation Confirms the Prognostic Superiority of the Endometrial Carcinoma Prognostic Index in International Federation of Gynecology and Obstetrics Stage 1 and 2 Endometrial Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.018

7 January 2021

Gynecologic oncology group trials in uterine corpus malignancies: recent progress

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.018

7 January 2021

Surgical stage I endometrial cancer: predictors of distant failure and death

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.018

7 January 2021

p53: oncogene or anti-oncogene?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.018

7 January 2021

The p53 tumour suppressor gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.018

7 January 2021

p53 mutations in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.018

7 January 2021

Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.018

7 January 2021

Correlation of metabolic stability and altered quaternary structure of oncoprotein p53 with cell transformation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.018

7 January 2021

Genetic basis for p53 overexpression in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.018

7 January 2021

Increased expression of mutant forms of p53 oncogene in primary lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.018

7 January 2021

Angiogenesis, p53, and bcl-2 expression as prognostic indicators in endometrial cancer: comparison with traditional clinicopathologic variables

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.018

7 January 2021

Nuclear DNA content, proliferative activity, and p53 expression related to clinical and histopathologic features in endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.018

7 January 2021

Overexpression of p53 protein is an independent prognostic indicator in human endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.018

7 January 2021

Mutant p53 protein as a predictor of survival in endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.018

7 January 2021

Pathologic expression of p53 or p16 in preoperative curettage specimens identifies high-risk endometrial carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.018

7 January 2021

A significance of immunohistochemical determination of steroid receptors, cell proliferation factor Ki-67 and protein p53 in endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.018

7 January 2021

p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.018

7 January 2021

p53 overexpression in advanced-stage endometrial adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.018

7 January 2021

TP53 protein expression analysis by luminometric immunoassay in comparison with gene mutation status and prognostic factors in early stage endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.018

7 January 2021

Immunohistochemical expression of cyclins, cyclin-dependent kinases, tumor-suppressor gene products, Ki-67, and sex steroid receptors in endometrial carcinoma: positive staining for cyclin A as a poor prognostic indicator

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.018

7 January 2021

Prognostic significance of the infiltrative pattern invasion in endometrioid adenocarcinoma of the endometrium

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.018

7 January 2021

Wilms Tumor Gene (WT1) and p53 expression in endometrial carcinomas: a study of 130 cases using a tissue microarray.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.018

7 January 2021

The prognostic value of PTEN, p53, and beta-catenin in endometrial carcinoma: a prospective immunocytochemical study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.018

7 January 2021

Increased expression of hypoxia-inducible factor 1alpha in type I and type II endometrial carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.018

7 January 2021

Association of p53 mutations and a codon 72 single nucleotide polymorphism with lower overall survival and responsiveness to adjuvant radiotherapy in endometrioid endometrial carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.018

7 January 2021

Functional analysis of p53 gene and the prognostic impact of dominant-negative p53 mutation in endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.018

7 January 2021

Identification of TP53 gene mutations in uterine corpus cancer with short follow-up

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.018

7 January 2021

Mutation and allelic loss of the p53 gene in endometrial carcinoma. Incidence and outcome in 92 surgical patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.018

7 January 2021

Prognostic value of p53 and K-ras-2 topographic genotyping in endometrial carcinoma: a clinicopathologic and molecular comparison

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.018

7 January 2021

Identification of p53 mutations in endometrial adenocarcinoma by polymerase chain reaction-single-strand conformation polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.018

7 January 2021

The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.018

7 January 2021

Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.018

7 January 2021

Simultaneous use of the PCR-SSCP method and immunohistochemistry for increasing the detection efficacy of p53 abnormalities in human lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.11.018

7 January 2021

Identifiers

10.1016/J.YGYNO.2009.11.018

1 reference

Europe PubMed Central

21 August 2017

1 reference

Europe PubMed Central

21 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37652620&oldid=2102675970"